A Reliable Albumin
Always in Position

Trusted since 2011 to supplement
your albumin needs1

How to Order

KEDbumin® [Albumin (human), USP] is a 25% albumin solution indicated for hypovolemia, hypoalbuminemia, prevention of central volume depletion after paracentesis due to cirrhotic ascites, ovarian hyperstimulation syndrome, adult respiratory distress syndrome, burns, hemodialysis patients undergoing long term dialysis, patients who cannot tolerate substantial volumes of salt solution, and in cardiopulmonary bypass procedures as part of the priming fluids.

Ordering KEDbumin

Product Size Grams
Albumin		 National
Drug Code
KEDbumin® 25
Albumin (Human) 25%, USP
 50 mL 12.5 g 76179-025-01
KEDbumin® 25
Albumin (Human) 25%, USP
 100 mL 25.0 g 76179-025-03

Order KEDbumin through the following authorized distributors:

BioCare SD  |  Medline  |  Henry Schein®  |  Cardinal Health™ Specialty Distribution  |  Cencora  |  CuraScript SD  |  FFF Enterprises  |  Lifeline  |  McKesson Medical-Surgical Inc.  |  McKesson Plasma and Biologics  |  Prodigy Health

Contact Kedrion Biopharma Customer Service

For pricing information or to place an order,
please contact Kedrion Biopharma Customer Service.

Customer service: 855.353.7466     Fax: 855.751.7951     Website: Kedrion.us

Hours: Mon-Fri / 8:00am – 6:00pm CT     Email: US_CustomerService@kedrion.com

Why Trust KEDbumin?

Reliable Support

phone icon

Dedicated Sales Force
855-353-7466

customer service icon

Passionate Customer
Service Team

shield icon

Trusted Since
2011

Team Player

  • Integrated Hanger

  • 36-Month Shelf Life

  • Easy-Open Packaging

  • Preservative-Free

  • Puncture-Proof Container

Learn About KEDbumin Viral Safety

KEDbumin is the result of an innovative manufacturing process that promotes viral clearance

The following steps are taken to ensure viral safety

Screening
plasma donors

Testing the
donated plasma

Inactivating and
removing viruses
during manufacturing

referee character

This process results in the reduction of:

  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Bovine Viral Diarrhea Virus (BVDV)
  • Pseudorabies Virus (PRV)
  • Reovirus (REO)
  • Porcine Parvovirus (PPO)
  • Hepatitis A Virus (HAV)
  • Encephalomyocarditis Virus (EMCV)

About Albumin

Albumin is a ubiquitous plasma protein that plays a major role in osmotic regulation

Albumin is responsible for:

  • Maintaining normal oncotic pressure within intravascular space
  • Binding and transporting molecules
  • Free radical scavenging
  • Hemostatic effects: platelet function inhibition and antithrombotic effects
  • Capillary membrane permeability
+

INDICATIONS AND USAGE

KEDBUMIN (albumin [human] injection) is a 25% albumin solution indicated for the following conditions:

Hypovolemia: For restoration and maintenance of circulating blood volume where volume deficiency is demonstrated and colloid use is appropriate.

Hypoalbuminemia: For severe albumin deficiency caused by illness or active bleeding. When albumin deficiency results from excessive protein loss, the effect of albumin administration will be temporary unless the underlying disorder is reversed.

Prevention of Central Volume Depletion after Paracentesis due to Cirrhotic Ascites: For maintenance of cardiovascular function following the removal of large volumes of ascitic fluid due to cirrhosis.

Ovarian Hyperstimulation Syndrome (OHSS): As a plasma expander in the fluid management of severe forms of OHSS.

Adult Respiratory Distress Syndrome (ARDS): In conjunction with diuretics to correct fluid volume overload associated with ARDS.

Burns: After more than 24 hours post burn in patients experiencing severe albumin depletion in order to favor edema re-absorption.

Hemodialysis: In patients undergoing long term dialysis or for those patients who are fluid-overloaded and cannot tolerate substantial volumes of salt solution for therapy of shock or hypotension.

Cardiopulmonary Bypass: In cardiopulmonary bypass procedures as part of the priming fluids.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

KEDBUMIN is contraindicated in severely anemic patients, patients with heart failure; and also in patients with a history of hypersensitivity to albumin, excipients used in its formulation, or components of the container.

WARNINGS AND PRECAUTIONS

Caution is advised where hypervolemia and its consequences or hemodilution could represent a special risk. Do not dilute with water for injections. Epinephrine should be available immediately to treat any acute hypersensitivity reaction. Be aware of the risk of transmission of infectious agents.

ADVERSE REACTIONS

The most common adverse reactions include fever, chills, rash, nausea, vomiting, tachycardia, and hypotension.

USE IN SPECIFIC POPULATIONS

Pediatric Use

The adult dose may be given in children 12-16 years of age. Use of KEDBUMIN in children less than 12 years of age has not been clinically evaluated. Adjust dosage in children based on the clinical state and body weight. Physicians should weigh the risks and benefits of using KEDBUMIN in the pediatric population.

To report SUSPECTED ADVERSE REACTIONS, contact KEDRION at
1-855-353-7466 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Reference: 1. KEDBUMIN® [Prescribing Information]. Kedrion Biopharma Inc. 2023.

For more details, please see the full Prescribing Information.

How
to
Order